Abstract
Earlier studies have shown that the bark of Salix L. species (Salicaceae family) is rich in extractives, such as diverse bioactive phenolic compounds. However, we lack knowledge on the bioactive properties of the bark of willow species and clones adapted to the harsh climate conditions of the cool temperate zone. Therefore, the present study aimed to obtain information on the functional profiles of northern willow clones for the use of value-added bioactive solutions. Of the 16 willow clones studied here, 12 were examples of widely distributed native Finnish willow species, including dark-leaved willow (S. myrsinifolia Salisb.) and tea-leaved willow (S. phylicifolia L.) (3 + 4 clones, respectively) and their natural and artificial hybrids (3 + 2 clones, respectively). The four remaining clones were commercial willow varieties from the Swedish willow breeding program. Hot water extraction of bark under mild conditions was carried out. Bioactivity assays were used to screen antiviral, antibacterial, antifungal, yeasticidal, and antioxidant activities, as well as the total phenolic content of the extracts. Additionally, we introduce a fast and less labor-intensive steam-debarking method for Salix spp. feedstocks. Clonal variation was observed in the antioxidant properties of the bark extracts of the 16 Salix spp. clones. High antiviral activity against a non-enveloped enterovirus, coxsackievirus A9, was found, with no marked differences in efficacy between the native clones. All the clones also showed antibacterial activity against Staphylococcus aureus and Escherichia coli, whereas no antifungal (Aspergillus brasiliensis) or yeasticidal (Candida albicans) efficacy was detected. When grouping the clone extract results into Salix myrsinifolia, Salix phylicifolia, native hybrid, artificial hybrid, and commercial clones, there was a significant difference in the activities between S. phylicifolia clone extracts and commercial clone extracts in the favor of S. phylicifolia in the antibacterial and antioxidant tests. In some antioxidant tests, S. phylicifolia clone extracts were also significantly more active than artificial clone extracts. Additionally, S. myrsinifolia clone extracts showed significantly higher activities in some antioxidant tests than commercial clone extracts and artificial clone extracts. Nevertheless, the bark extracts of native Finnish willow clones showed high bioactivity. The obtained knowledge paves the way towards developing high value-added biochemicals and other functional solutions based on willow biorefinery approaches.
Highlights
Willows correspond to approximately 450 species of deciduous trees and shrubs, which are mostly found in moist soils of the Northern Hemisphere (Christenhusz et al, 2017)
We introduced a steam debarking method, which loosens the bark and allows its efficient removal; this method has the potential to decrease the costs of willow debarking
Our results showed that some antioxidant activity was lost in the steam-treated bark samples
Summary
Willows (genus Salix L.) correspond to approximately 450 species of deciduous trees and shrubs, which are mostly found in moist soils of the Northern Hemisphere (Christenhusz et al, 2017). Willow leaves and bark have long been known as herbal medicines because of their ability to relieve fever and aches. These properties have been attributed to compounds identified from willow species, such as salicinoids and various polyphenols. Most of the salicinoids are signature compounds of Salix and Populus L. species, and over 20 individual salicinoids have been characterized. Other small phenolic glycosides common in willow bark are picein, a glucoside of hydroxyacetophenone, salidroside, a glucoside of phenylethanoid, and derivatives of cinnamic alcohols such as triandrin and vimalin (Julkunen-Tiitto, 1985; Kammerer et al, 2005; Dou et al, 2018). A comprehensive review of the phytochemistry and pharmacological activities of Salix spp. was recently published by Tawfeek et al (2021)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
